Dr. Massengill is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
900 NW 17th St
Miami, FL 33136Phone+1 305-326-6000
Summary
- I am seeking a position in Vitreoretinal Surgery upon completion of my fellowship at the Bascom Palmer Eye Institute in July 2026. My training has provided extensive experience in general vitreoretinal surgery, with a strong focus on both clinical practice and research.
I have a particular interest in practicing general vitreoretinal surgery while also participating in clinical trials and advancing care for inherited retinal diseases. My MD-PhD research at the University of Florida focused on developing gene therapy strategies for retinitis pigmentosa, and I remain passionate about applying cutting-edge science to patient care.
Florida holds deep personal and professional significance for me. I completed my undergraduate studies at the University of South Florida, pursued my MD-PhD at the University of Florida, and am now completing my fellowship training at the University of Miami. Additionally, my wife practices patent law in Florida, further strengthening our ties to the region.
I am eager to contribute to a Vitreoretinal surgery practice where I can provide patient-centered and cutting-edge care, and I would welcome the opportunity to discuss how my skills and experiences align with the needs of any interested practices.
Education & Training
- University of Illinois College of Medicine at ChicagoResidency, Ophthalmology, 2020 - 2024
- University of Florida College of MedicineClass of 2020
Certifications & Licensure
- FL State Medical License 2024 - 2026
- IL State Medical License 2020 - 2024
Publications & Presentations
PubMed
- Recurrent Intraocular Hemorrhage after Scleral Sutured Intraocular Lens.Michael T Massengill, Boris Kalitenko, Harry W Flynn
Ophthalmology. 2025-02-04 - Outcomes of Open-Globe Injuries With Associated Retinal Detachment: Experience at an Ocular Trauma Center.Neil Sheth, Arthur Y Chang, John M Bryan, Michael T Massengill, Jennifer I Lim
Journal of Vitreoretinal Diseases. 2024-12-13 - 2 citationsResponse of Diabetic Macular Edema to Anti-VEGF Medications Correlates with Improvement in Macular Vessel Architecture Measured with OCT Angiography.Michael T Massengill, Samuel Cubillos, Neil Sheth, Abhishek Sethi, Jennifer I Lim
Ophthalmology Science. 2024-01-26
Journal Articles
- Clinically Relevant Outcome Measures for the I307N Rhodopsin Mouse: A Model of Inducible Autosomal Dominant Retinitis PigmentosaMichael Massengill, MD, Investigative Ophthalmology and Visual Science
- Mutation-Independent Rhodopsin Gene Therapy by Knockdown and Replacement with a Single AAV VectorMichael T Massengill, Samuel G Jacobson, Proceedings of the National Academy of Sciences
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: